Last update:
Medications news
Medications
Trump says he takes high-dose aspirin, links it to hand bruising
President Donald Trump, 79, says he takes a higher daily dose of aspirin than his doctors recommend, a choice he says explains the bruising that's often seen on his hands.
1 hour ago
0
0
Medications
Coloradans snap up over-the-counter naloxone while hospitals offer the overdose-reversal drug to more patients
Colorado is coming closer to universal access to overdose-reversing medication as residents snap up an over-the-counter version and hospitals offer it to more patients.
Dec 31, 2025
0
0
Visiting abroad in the coming year? Antibiotics becoming less effective against traveler's diarrhea, study warns
Planning some international travel as one of your New Year's resolutions?
Dec 30, 2025
0
1
FDA approves Jascayd for progressive pulmonary fibrosis
The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults.
Dec 30, 2025
0
1
Prescribing of some controlled medications has decreased in youth over past two decades
In the past two decades, there were decreases in prescribing of some controlled medications to adolescents and young adults, according to a study published online Dec. 15 in Drug and Alcohol Dependence.
Dec 30, 2025
0
0
Tirzepatide noninferior to dulaglutide for CV outcomes in type 2 diabetes
Tirzepatide is noninferior to dulaglutide with respect to a composite of death from cardiovascular (CV) causes, myocardial infarction, or stroke among patients with type 2 diabetes and atherosclerotic CV disease, according ...
Dec 30, 2025
0
0
New antivirals are being tested for herpesviruses, and scientists now know how they work
Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.
Dec 29, 2025
0
41
Breast cancer drug boosts leukemia treatment: Unexpected duo shows promise in overcoming resistance
A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia overcome resistance to one of the most common frontline therapies.
Dec 29, 2025
0
80
Email reminders boost use of database for safe prescribing
A new randomized clinical trial finds that simple reminder emails substantially increase clinicians' use of a database that supports safe prescribing of opioids and other drugs, even though opioid prescribing patterns themselves ...
Dec 29, 2025
0
0
New study suggests best way to stop taking antidepressants
The best way for people with depression to stop taking antidepressants once their condition improves is to slowly taper off the medication while also receiving psychological support, new research suggested Thursday.
Dec 27, 2025
0
44
Worried about statins? Here's what the evidence shows
Few medicines have sparked as much debate as statins. Cardiologists often describe them as life-saving, while some patients remain wary of side effects or uneasy about taking a daily pill.
Dec 26, 2025
0
3
Iron-snatching compounds found to be effective against parasitic flatworm
A series of compounds that deprive iron essential for a parasitic worm could provide effective new agents for blocking parasite growth, a RIKEN researcher has found. This finding, published in the journal Tropical Medicine ...
Dec 23, 2025
0
31
Novo Nordisk says US approves first GLP-1 pill for weight loss
Danish pharmaceutical giant Novo Nordisk announced Monday the US Food and Drug Administration (FDA) had approved its popular GLP-1 anti-obesity drug Wegovy to be administered in pill form for weight loss.
Dec 23, 2025
0
0
FDA approves first subcutaneous drug for EGFR-mutated non-small cell lung cancer
The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneously administered therapy for patients with epidermal growth factor receptor (EGFR)-mutated ...
Dec 23, 2025
0
1
Antiviral trial ties valacyclovir to faster cognitive decline
New York State Psychiatric Institute and Columbia University Medical Center investigators, with co-authors across additional US centers, report greater cognitive worsening at 78 weeks with valacyclovir than with placebo among ...
Cannabis products with more THC can slightly reduce pain but cause more side effects
A new systematic evidence review finds that cannabis products that carry relatively high levels of the psychoactive compound tetrahydrocannabinol, commonly known as THC, may provide short-term improvements in pain and function.
Dec 22, 2025
0
2
Natural protein drug may slow neuron death linked to Alzheimer's disease
Scientists at the University of Colorado Anschutz have discovered that while brain neuron changes, including cell loss, may begin in early life, a drug long-approved for other conditions might be repurposed to slow this damage, ...
Dec 20, 2025
0
95
Combined oral contraceptive use among people with migraine with aura persists, despite cautions
Current medical guidelines discourage the use of combined oral contraceptives (COCs) among people who experience migraine with aura—a type of migraine accompanied by temporary neurological symptoms—due to a heightened ...
Dec 19, 2025
0
0
Study finds 40% of GLP-1 prescriptions go unfilled: Is cost curbing use of weight loss drugs?
Popular new anti-obesity medications can help people lose 10% to 20% of their body weight, yet a new study indicates that about 40% of those prescriptions go unfilled. Affordability, say researchers, is likely a factor.
Dec 18, 2025
0
29
Researchers seek better, safer alternatives to current opioid drugs
Researchers at USF Health are making dramatic strides in understanding how new opioid compounds work inside the body to provide pain relief, offering greater hope that new classes of these drugs may eventually be used to ...
Dec 18, 2025
0
0
High-dose antibiotic does not reduce mortality in tuberculous meningitis, clinical trial finds
A higher dose of the antibiotic rifampicin does not improve survival rates for patients with tuberculous meningitis. This severe form of tuberculosis causes inflammation of the brain membranes, and half of the patients die. ...
Dec 17, 2025
0
0
Antimalarial drug candidate shows potential for fighting resistance and reducing malaria transmission
Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and potentially reduce malaria transmission.
Dec 17, 2025
0
0
FDA approves Waskyra for Wiskott-Aldrich syndrome
The U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel) as the first cell-based gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS).
Dec 16, 2025
0
0
FDA approves oral Nuzolvence and Blujepa for treating uncomplicated gonorrhea
The U.S. Food and Drug Administration recently approved two new oral medicines to treat the sexually transmitted infection gonorrhea.
Dec 16, 2025
0
0
Little awareness of medical and psychological complexities of steroid cream withdrawal
There is little awareness, particularly among clinicians, of the medical and psychological complexities of "topical steroid withdrawal"—the body's adverse response to the prolonged use of these powerful creams to treat ...
Dec 16, 2025
0
1
